GPCR screening & profiling

Functional, validated cell-based assays for Drug Discovery

ChanTest’s GPCR screening panel includes over 125 targets, and includes receptors from all major GPCR classes. All assays are fully validated and have been designed to provide high quality screening and profiling data for both drug discovery and safety assessments.

Instrumentation: FLIPRTETRA®, FlexStation® 3

Readouts: cAMP, calcium, membrane potential, binding

GPCR Screening: Cell-based screens performed with calcium-sensitive or membrane-potential-sensitive dyes. Gs- and Gi-coupled GPCRs are assayed via cAMP determinations using either a cell-based real time cAMP assay or other validated cAMP assay platform. EC50 / IC50 determinations on confirmed actives are offered as a follow-up option. All screens include positive controls and a comprehensive report.

GPCR Profiling: Compound profiling against multiple receptors to determine specificity or off-target activity.

Mode of Action Studies: Full characterization of orthostatic and allosteric ligands.

GPCR Functional Selectivity: Measurement of GPCR functional selectivity and differentiation from assay format artefacts.

ChanTest Compound Library: Our diverse, custom-made compound library consists of 12,600 compounds (40 384-well plates). Library screen turnaround is one business week and includes EC50 / IC50 follow-up of confirmed actives identified in the screen.

To receive a quote or for additional information, please email inquiries@chantest.com or call 216-332-1665. Check back regularly for an updated listing of available targets.

 

TargetReceptorValidation*
5-HT6SerotoninBND
5HT1ASerotoninBND, cAMP
5HT2BSerotoninCA
5HT2bSerotoninBND, cAMP
5HT2cSerotoninBND
A1AdenosinecAMP
A2ThromboxaneBND
A3AdenosinecAMP
Alpha1aAdrenergicCA
Alpha2aAdrenergicBND, cAMP
Alpha2bAdrenergicBND, cAMP
Alpha2cAdrenergicBND, cAMP
AT1AngiotensinCA
BB2BombesinCA
CB1CannabinoidBND, cAMP
CB1CannabinoidBND, cAMP
CB2CannabinoidBND, cAMP
CB2CannabinoidcAMP
CCKACholecystokininCA
CCKBCholecystokininCA
CCR2BChemokinecAMP
DeltaOpioidcAMP
EDG1 (S1P1)LysophospholipidBND, cAMP
ETAEndothelinCA
ETBEndothelinCA
FPRL1FormylpeptideBND, CA
FPRL1FormylpeptideCA
GIPRGastric Inhibitory PolypeptideBND, cAMP
GPR103RFamide peptideCA
GPR119Free Fatty AcidcAMP
GPR120Free Fatty AcidCA
GPR40Free Fatty AcidCA
GPR41Free Fatty AcidCA
GPR43Free Fatty AcidCA
H1HistamineCA
KappaOpioidcAMP
LPA1Lysophosphatidic AcidBND, cAMP
LPA4LysophospholipidCA
m1AcetylcholineBND, CA
m2MuscarinicBND, cAMP
m3AcetylcholineBND, CA
m4AcetylcholineBND, cAMP
m4MuscarinicBND, cAMP
m5AcetylcholineBND, CA
MC1MelanocortincAMP
Mrg-X1Mas-relatedCA
Mrg-X2Mrg-X2CA
MuOpioidcAMP
NTSR1NeurotensinCA
ORL1OpioidcAMP
OTROxytocinCA
OX1OrexinBND, CA
OX2OrexinBND, CA
P2Y1PurinergicCA
P2Y11PurinergicCA
P2Y12PurinergicCA
P2Y6PurinergicCA
PAR1Protease-ActivatedCA
PAR2Protease-ActivatedBND, CA
PAR4Protease-ActivatedCA
PKR2ProkineticinCA
RXFP4RelaxinBND, CA
SSTR4SomatostatinBND, CA
SSTR5SomatostatinBND, CA
V1aVasopressinBND, CA
V1bVasopressinBND, CA
V2VasopressinBND, CA
β2AdrenergiccAMP
CA: calcium - cAMP: cyclic AMP - CNG: cell membrane depolarization - BND: binding

 

Download: GPCR targets and assay readout pdf.